|43.03||-1.57 / -3.52%|
As of 4:14pm ET
|43.03||0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 50.00, with a high estimate of 61.00 and a low estimate of 44.00. The median estimate represents a +16.20% increase from the last price of 43.03.
The current consensus among 4 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.